Improving Care for Patients With Chronic Kidney Disease Using EMRALD

Chronic Kidney Disease Clinical Trial

Official title:

Improving Care for Patients With Chronic Kidney Disease Using Electronic Medical Record Interventions: A Pragmatic Cluster Randomized Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02274298
• Other study ID #: 074-2013-2
• Status: Active, not recruiting
• Phase: N/A
• First received: October 6, 2014
• Last updated: October 13, 2016
• Start date: October 2014
• Est. completion date: April 2017

Study information

• Verified date: October 2016
• Source: Sunnybrook Health Sciences Centre
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Interventional

Clinical Trial Summary

This pragmatic cluster randomized controlled trial will test the impact of feedback and a toolkit aimed at improving the management of chronic kidney disease (CKD) in the primary care setting. This trial will use family physicians in Ontario participating in the Electronic.

Description:

This trial will use family physicians in Ontario participating in the Electronic Medical Record Administrative data Linked Database (EMRALD) and receiving the System for Audit and Feedback to Improve caRE (SAFIRE) along with other decision support tools. Performance on CKD quality indicators for family physicians receiving the CKD feedback and tools will be compared to physicians not receiving the CKD feedback or tools.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 221
• Est. completion date: April 2017
• Est. primary completion date: April 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Family physicians participating in EMRALD, on the EMR for >=2 years, roster size >=100 patients

• Patient criteria, rostered and actively seeing an EMRALD physician, on the EMR for .=1 year

Exclusion Criteria:

• Updated data available at the time of study commencement

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Chronic Kidney Disease
• Kidney Diseases
• Renal Insufficiency, Chronic

Intervention

Behavioral:
• CKD feedback and tools
people in the intervention arm will receive feedback on ckd quality indicators and tools to help in the detection and management of ckd

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Sunnybrook Health Sciences Centre	Ontario Renal Network

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of patients age 50-80 with Stage 3+ CKD and a statin prescription	Comparison of proportion of patients age 50-80 years with Stage 3+ CKD (no dialysis or renal transplant) and receiving a statin prescription at baseline and at the end of the trial	24 months	No
Secondary	Proportion of patients at high risk screened for CKD with an eGFR and/or ACR	compare baseline rates to end of intervention rates	24 months	No
Secondary	Proportion of patients with an initial eGFR <60 and a f/u eGFR or an ACR	compare baseline rates to end of intervention rates	24 months	No
Secondary	Proportion of patients with diabetes and albuminuria and on an ACE or ARB	compare baseline rates to end of intervention rates	24 months	No
Secondary	Proportion of patients meeting eGFR criteria for CKD and documentation of CKD in the cumulative patient profile (CPP)	compare baseline rates to end of intervention rates	24 months	No
Secondary	Proportion of patients with an ACR in the past 18 months and meeting bp targets	compare baseline rates to end of intervention rates	24 months	No
Secondary	Proportion of patients age less than 80 years and an eGFR<30 being seen by or with a referral to a Nephrologist	compare baseline rates to end of intervention rates	24 months	No